Welcome to our dedicated page for Kindly Md SEC filings (Ticker: NAKA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Kindly Md's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Kindly Md's regulatory disclosures and financial reporting.
Kindly MD, Inc. (NAKA) reporting person Andrew Creighton disclosed direct beneficial ownership of 892,857 shares of common stock on a Form 3 filed for the 08/14/2025 event. The filing identifies Mr. Creighton as a director and as Chief Compliance Officer and is signed 08/19/2025. The Form 3 documents initial ownership and includes Exhibit 24 (Power of Attorney).
David F. Bailey, who is listed as both Chief Executive Officer and a Director of Kindly MD, Inc. (NAKA), reported a transaction dated 08/14/2025 on Form 4. The filing shows an acquisition of 11,160,572 shares of Common Stock at a reported price of $0. Following the transaction, Mr. Bailey is reported to beneficially own 11,160,572 shares in a direct ownership form. The Form 4 is signed by Mr. Bailey on 08/15/2025.
Kindly MD, Inc. (NAKA) amended its corporate authorizations and conduct rules. The company increased authorized capital from 110,000,000 shares to 10,010,000,000 total shares, consisting of 10,000,000,000 shares of common stock (par value $0.001) and 10,000,000 shares of preferred stock (par value $0.001).
The company also expanded its Code to expressly cover consultants and contractors in addition to directors, officers, and employees, broadening who is bound by the company’s conduct rules. An exhibit list is referenced but not fully shown in the provided content.
Mark W. Yusko, a director of Kindly MD, Inc. (NAKA), reports direct beneficial ownership of 2,100,000 shares of the company's common stock. The filing is an initial disclosure of ownership under Section 16, showing the director holds the shares directly rather than through an indirect vehicle. The statement documents ownership but does not disclose any derivative holdings or changes in compensation or transactions.
Kindly MD, Inc. (NAKA) initial Form 3 discloses that Gregory Xethalis filed an insider statement as a director and reported no securities beneficially owned in the issuer. The filing lists a business address and indicates the form was filed by one reporting person. An exhibit references a Power of Attorney. The document is an initial statement of beneficial ownership and contains no entries in the non-derivative or derivative tables, indicating the reporting person holds no direct or indirect equity positions reported on this form.
Kindly MD, Inc. (NAKA) Form 3 filed by Amanda Fabiano reports her relationship to the issuer as a Director and Chief Operating Officer and is dated 08/14/2025. The filing states no securities are beneficially owned by the reporting person and includes an Exhibit 24 - Power of Attorney. The form is an initial statement of beneficial ownership and is signed by Amanda Fabiano.
Perianne Boring submitted an initial Form 3 for Kindly MD, Inc. (ticker NAKA) dated 08/14/2025. Ms. Boring is reported as a Director and the filing states she does not beneficially own any securities of the issuer. The form is signed by the reporting person and references an Exhibit 24 (Power of Attorney). No non-derivative or derivative holdings are listed.
David F. Bailey, listed at 5097 S 900 E Suite 100, Salt Lake City, UT 84117, filed an Initial Statement of Beneficial Ownership (Form 3) for Kindly MD, Inc. (NAKA) on 08/14/2025. The filing identifies Mr. Bailey as both a Director and the Chief Executive Officer and notes the form was filed by one reporting person. The filing expressly states no securities are beneficially owned and includes an Exhibit 24 power of attorney. The report is signed by David Bailey.